Hanri Afghahi, Salmir Nasic, Johan Svensson, Helena Rydell, Anna Wärme, Björn Peters
{"title":"在血液透析和腹膜透析中，糖尿病合并终末期肾病患者的体重指数与死亡率之间的关系是不同的。","authors":"Hanri Afghahi, Salmir Nasic, Johan Svensson, Helena Rydell, Anna Wärme, Björn Peters","doi":"10.1080/0886022X.2025.2510549","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and hypothesis: </strong>There are diverse results in terms of the association between body mass index (BMI) and mortality risk in patients with end-stage renal disease (ESRD). The aim was to examine if there is an association between BMI and the risk of all-cause mortality in patients with diabetes mellitus (DM) and ESRD on hemodialysis (HD) or peritoneal dialysis (PD).</p><p><strong>Methods: </strong>Included were 3,235 patients (mean age 66 ± 14 years, 66% men) with DM on dialysis treatment (2,452 HD, 783 PD) that were followed for 3.9 ± 3.5 years. BMI was calculated as weight (kg)/[height (m)]<sup>2</sup> and defined as the mean BMI value during the study period. Relationships between BMI and all-cause mortality were examined by Cox-models to estimate hazard ratios (HR) and 95% confidence intervals (CI) in univariate and multivariate analyses adjusted for demographics, laboratory findings and comorbidity. BMI between 18.5 and 25 kg/m<sup>2</sup> was used as the reference group.</p><p><strong>Results: </strong>During the study, 1,688 (53%) patients died (1,275 on HD, 413 on PD). In multivariate analyses, patients on HD with BMI ≤ 18.5 kg/m<sup>2</sup> had an increased risk of all-cause mortality (HR1.94, CI 1.47-2.54). In contrast, mortality risk was decreased in the BMI groups of 25.1-30 kg/m<sup>2</sup> (HR0.84, CI0.73-0.96), 30.1-35 kg/m<sup>2</sup> (HR0.66, CI0.55-0.78), and 35.1-40 kg/m<sup>2</sup> (HR0.65, CI0.49-0.85). In multivariate analyses, no associations between BMI and mortality risk were found in patients on PD.</p><p><strong>Conclusion: </strong>An increased risk of mortality in underweight DM patients on HD was found. Overweight, class 1 and class 2 obesity were associated with better survival in HD.</p><p><strong>Key learning points: </strong>The association between BMI and risk of mortality is different in patients with DM on maintenance HD or PD.</p><p><strong>What was known (maximum 50 words): </strong>The association between BMI and risk of mortality in ESRD population on dialysis treatment is very divers and different study have shown different results.</p><p><strong>This study adds (maximum 50 words): </strong>High BMI associated with better survival in patients with diabetes and HD but this finding did not observed with PD.</p><p><strong>Potential impact (on practice or understanding, maximum 50 words): </strong>The importance to examine time-varying BMI frequently as independent covariance in patients with dialysis treatment.</p>","PeriodicalId":20839,"journal":{"name":"Renal Failure","volume":"47 1","pages":"2510549"},"PeriodicalIF":3.0000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12123957/pdf/","citationCount":"0","resultStr":"{\"title\":\"The association between body mass index and mortality in diabetic patients with end-stage renal disease is different in hemodialysis and peritoneal dialysis.\",\"authors\":\"Hanri Afghahi, Salmir Nasic, Johan Svensson, Helena Rydell, Anna Wärme, Björn Peters\",\"doi\":\"10.1080/0886022X.2025.2510549\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and hypothesis: </strong>There are diverse results in terms of the association between body mass index (BMI) and mortality risk in patients with end-stage renal disease (ESRD). The aim was to examine if there is an association between BMI and the risk of all-cause mortality in patients with diabetes mellitus (DM) and ESRD on hemodialysis (HD) or peritoneal dialysis (PD).</p><p><strong>Methods: </strong>Included were 3,235 patients (mean age 66 ± 14 years, 66% men) with DM on dialysis treatment (2,452 HD, 783 PD) that were followed for 3.9 ± 3.5 years. BMI was calculated as weight (kg)/[height (m)]<sup>2</sup> and defined as the mean BMI value during the study period. Relationships between BMI and all-cause mortality were examined by Cox-models to estimate hazard ratios (HR) and 95% confidence intervals (CI) in univariate and multivariate analyses adjusted for demographics, laboratory findings and comorbidity. BMI between 18.5 and 25 kg/m<sup>2</sup> was used as the reference group.</p><p><strong>Results: </strong>During the study, 1,688 (53%) patients died (1,275 on HD, 413 on PD). In multivariate analyses, patients on HD with BMI ≤ 18.5 kg/m<sup>2</sup> had an increased risk of all-cause mortality (HR1.94, CI 1.47-2.54). In contrast, mortality risk was decreased in the BMI groups of 25.1-30 kg/m<sup>2</sup> (HR0.84, CI0.73-0.96), 30.1-35 kg/m<sup>2</sup> (HR0.66, CI0.55-0.78), and 35.1-40 kg/m<sup>2</sup> (HR0.65, CI0.49-0.85). In multivariate analyses, no associations between BMI and mortality risk were found in patients on PD.</p><p><strong>Conclusion: </strong>An increased risk of mortality in underweight DM patients on HD was found. Overweight, class 1 and class 2 obesity were associated with better survival in HD.</p><p><strong>Key learning points: </strong>The association between BMI and risk of mortality is different in patients with DM on maintenance HD or PD.</p><p><strong>What was known (maximum 50 words): </strong>The association between BMI and risk of mortality in ESRD population on dialysis treatment is very divers and different study have shown different results.</p><p><strong>This study adds (maximum 50 words): </strong>High BMI associated with better survival in patients with diabetes and HD but this finding did not observed with PD.</p><p><strong>Potential impact (on practice or understanding, maximum 50 words): </strong>The importance to examine time-varying BMI frequently as independent covariance in patients with dialysis treatment.</p>\",\"PeriodicalId\":20839,\"journal\":{\"name\":\"Renal Failure\",\"volume\":\"47 1\",\"pages\":\"2510549\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12123957/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Renal Failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/0886022X.2025.2510549\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Renal Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/0886022X.2025.2510549","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
The association between body mass index and mortality in diabetic patients with end-stage renal disease is different in hemodialysis and peritoneal dialysis.
Background and hypothesis: There are diverse results in terms of the association between body mass index (BMI) and mortality risk in patients with end-stage renal disease (ESRD). The aim was to examine if there is an association between BMI and the risk of all-cause mortality in patients with diabetes mellitus (DM) and ESRD on hemodialysis (HD) or peritoneal dialysis (PD).
Methods: Included were 3,235 patients (mean age 66 ± 14 years, 66% men) with DM on dialysis treatment (2,452 HD, 783 PD) that were followed for 3.9 ± 3.5 years. BMI was calculated as weight (kg)/[height (m)]2 and defined as the mean BMI value during the study period. Relationships between BMI and all-cause mortality were examined by Cox-models to estimate hazard ratios (HR) and 95% confidence intervals (CI) in univariate and multivariate analyses adjusted for demographics, laboratory findings and comorbidity. BMI between 18.5 and 25 kg/m2 was used as the reference group.
Results: During the study, 1,688 (53%) patients died (1,275 on HD, 413 on PD). In multivariate analyses, patients on HD with BMI ≤ 18.5 kg/m2 had an increased risk of all-cause mortality (HR1.94, CI 1.47-2.54). In contrast, mortality risk was decreased in the BMI groups of 25.1-30 kg/m2 (HR0.84, CI0.73-0.96), 30.1-35 kg/m2 (HR0.66, CI0.55-0.78), and 35.1-40 kg/m2 (HR0.65, CI0.49-0.85). In multivariate analyses, no associations between BMI and mortality risk were found in patients on PD.
Conclusion: An increased risk of mortality in underweight DM patients on HD was found. Overweight, class 1 and class 2 obesity were associated with better survival in HD.
Key learning points: The association between BMI and risk of mortality is different in patients with DM on maintenance HD or PD.
What was known (maximum 50 words): The association between BMI and risk of mortality in ESRD population on dialysis treatment is very divers and different study have shown different results.
This study adds (maximum 50 words): High BMI associated with better survival in patients with diabetes and HD but this finding did not observed with PD.
Potential impact (on practice or understanding, maximum 50 words): The importance to examine time-varying BMI frequently as independent covariance in patients with dialysis treatment.
期刊介绍：
Renal Failure primarily concentrates on acute renal injury and its consequence, but also addresses advances in the fields of chronic renal failure, hypertension, and renal transplantation. Bringing together both clinical and experimental aspects of renal failure, this publication presents timely, practical information on pathology and pathophysiology of acute renal failure; nephrotoxicity of drugs and other substances; prevention, treatment, and therapy of renal failure; renal failure in association with transplantation, hypertension, and diabetes mellitus.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
